{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:09:57Z","timestamp":1764238197669,"version":"3.40.5"},"reference-count":55,"publisher":"American Academy of Pediatrics (AAP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:p>With more and more reproductive-aged women opting to pursue genetic screening during pregnancy, health care professionals must understand the variety of testing options available as well as the advantages and limitations of each testing option. Presently, no single screening test is universally believed to be superior because the combination of the specific test and the population being tested determines the range of potential identifiable conditions as well as the positive predictive values. As a result, pre- and posttest counseling are not always straightforward and may require discussions with multiple specialists including genetic counselors, obstetricians, and pediatricians\/neonatologists. The purpose of this review is to summarize the screening options currently available to pregnant women to determine their risk of having a child affected by a chromosomal disorder. Screening for chromosomal abnormalities using ultrasonography, maternal serum analytes, cell-free DNA, and preimplantation genetic testing will be discussed here. Advances in the field, including the possible future use of cell-based noninvasive prenatal screening (NIPS) as a more accurate method for genetic screening and the incorporation of screening for copy number variants (microdeletions and duplications) into traditional cell-free NIPS will also be reviewed.<\/jats:p>","DOI":"10.1542\/neo.22-12-e805","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:25:35Z","timestamp":1638339935000},"page":"e805-e818","source":"Crossref","is-referenced-by-count":5,"title":["Fetal Screening for Chromosomal Abnormalities"],"prefix":"10.1542","volume":"22","author":[{"given":"Desiree G.","family":"Fiorentino","sequence":"first","affiliation":[{"name":"Montefiore Medical Center\/Albert Einstein College of Medicine, Department of Obstetrics & Gynecology and Women\u2019s Health, Division of Maternal-Fetal Medicine, Bronx, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Hughes","sequence":"additional","affiliation":[{"name":"Montefiore Medical Center\/Albert Einstein College of Medicine, Department of Obstetrics & Gynecology and Women\u2019s Health, Division of Maternal-Fetal Medicine, Bronx, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"4","key":"2021121010415127600_B1","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226","volume":"136","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2021121010415127600_B2","volume-title":"Thompson & Thompson Genetics in Medicine","author":"Nussbaum","year":"2016","edition":"8th ed."},{"issue":"18","key":"2021121010415127600_B3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/bdr2.1589","article-title":"National population-based estimates for major birth defects, 2010-2014","volume":"111","author":"Mai","year":"2019","journal-title":"Birth Defects Res"},{"issue":"1","key":"2021121010415127600_B4","first-page":"37","article-title":"Second-trimester diagnosis of triploidy: a series of four cases","volume":"3","author":"Wick","year":"2013","journal-title":"AJP Rep"},{"issue":"5","key":"2021121010415127600_B5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ejhg.2011.246","article-title":"Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe","volume":"20","author":"Wellesley","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"2021121010415127600_B6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000000452","article-title":"Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing","volume":"124","author":"Norton","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021121010415127600_B7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pd.4054","article-title":"Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center","volume":"33","author":"Alamillo","year":"2013","journal-title":"Prenat Diagn"},{"issue":"19","key":"2021121010415127600_B8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down\u2019s syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121010415127600_B9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.2007.01238.x","article-title":"Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice","volume":"114","author":"Weisz","year":"2007","journal-title":"BJOG"},{"issue":"4","key":"2021121010415127600_B10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.AOG.0000139832.79658.b9","article-title":"Sequential pathways of testing after first-trimester screening for trisomy 21","volume":"104","author":"Platt","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2021121010415127600_B11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.semperi.2005.05.004","article-title":"Down syndrome screening in the first and\/or second trimester: model predicted performance using meta-analysis parameters","volume":"29","author":"Cuckle","year":"2005","journal-title":"Semin Perinatol"},{"key":"2021121010415127600_B12","volume-title":"Maternal Fetal Medicine Principles and Practice","author":"Resnik","year":"2019","edition":"8th ed."},{"issue":"4","key":"2021121010415127600_B13","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2021121010415127600_B14","first-page":"CD011202","article-title":"Use of biochemical tests of placental function for improving pregnancy outcome","author":"Heazell","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2021121010415127600_B15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1469-0705.1998.11060407.x","article-title":"Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks\u2019 gestation","volume":"11","author":"Van Vugt","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"2021121010415127600_B16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.semperi.2006.01.001","article-title":"Down syndrome screening in the first and second trimesters: what do the data show?","volume":"29","author":"Rosen","year":"2005","journal-title":"Semin Perinatol"},{"issue":"10","key":"2021121010415127600_B17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7863\/jum.2002.21.10.1087","article-title":"The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester","volume":"21","author":"Bromley","year":"2002","journal-title":"J Ultrasound Med"},{"key":"2021121010415127600_B18","article-title":"Society for Maternal-Fetal Medicine (SMFM) consult series #57: evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester [published online ahead of print June 22, 2021]","author":"Society for Maternal-Fetal Medicine (SMFM)","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2021121010415127600_B19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00439-019-02061-1","article-title":"Noninvasive prenatal testing: from aneuploidy to single genes","volume":"139","author":"Guseh","year":"2020","journal-title":"Hum Genet"},{"issue":"4","key":"2021121010415127600_B20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/uog.15995","article-title":"Utility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy","volume":"49","author":"Vora","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"2021121010415127600_B21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000355655","article-title":"Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood","volume":"35","author":"Nicolaides","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"5","key":"2021121010415127600_B22","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021121010415127600_B23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"26","key":"2021121010415127600_B24","first-page":"2582","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"373","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121010415127600_B25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks\u2019 gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"2021121010415127600_B26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/pd.4804","article-title":"The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon","volume":"36","author":"Yaron","year":"2016","journal-title":"Prenat Diagn"},{"key":"2021121010415127600_B27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.05.027","article-title":"Obesity and no call results: optimal timing of cell-free DNA testing and redraw [published online ahead of print April 8, 2021]","author":"Hopkins","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2021121010415127600_B28","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/gim.2017.219","article-title":"Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results","volume":"20","author":"Bianchi","year":"2018","journal-title":"Genet Med"},{"issue":"2 pt 1","key":"2021121010415127600_B29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2021121010415127600_B30","doi-asserted-by":"crossref","first-page":"666648","DOI":"10.3389\/fgene.2021.666648","article-title":"Follow-up in patients with non-invasive prenatal screening failures: a reflection on the choice of further prenatal diagnosis","volume":"12","author":"Liu","year":"2021","journal-title":"Front Genet"},{"issue":"11","key":"2021121010415127600_B31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/gim.2018.22","article-title":"Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing","volume":"20","author":"Palomaki","year":"2018","journal-title":"Genet Med"},{"issue":"6","key":"2021121010415127600_B32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/pd.4123","article-title":"Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples","volume":"33","author":"Futch","year":"2013","journal-title":"Prenat Diagn"},{"issue":"1","key":"2021121010415127600_B33","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"journal-title":"Prenat Diagn","article-title":"Temporal persistence of residual fetal cell-free DNA from a deceased cotwin after selective fetal reduction in dichorionic diamniotic twin pregnancies. [published online ahead of print January 13, 2021]","author":"Chen","key":"2021121010415127600_B34"},{"issue":"8","key":"2021121010415127600_B35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/gim.2017.91","article-title":"Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"19","author":"Cherry","year":"2017","journal-title":"Genet Med"},{"issue":"3","key":"2021121010415127600_B36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pd.4778","article-title":"Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling","volume":"36","author":"Snyder","year":"2016","journal-title":"Prenat Diagn"},{"issue":"2","key":"2021121010415127600_B37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"2021121010415127600_B38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/AOG.0000000000002474","article-title":"Maternal Malignancy Evaluation After Discordant Cell-Free DNA Results","volume":"131","author":"Carlson","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2021121010415127600_B39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/uog.15985","article-title":"Discordant anomalies and karyotype in a monochorionic twin pregnancy: a call for comprehensive genetic evaluation","volume":"49","author":"Rock","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"2021121010415127600_B40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/pd.5255","article-title":"Unusual twinning: Additional findings during prenatal diagnosis of twin zygosity by single nucleotide polymorphism (SNP) array","volume":"38","author":"Zou","year":"2018","journal-title":"Prenat Diagn"},{"issue":"12","key":"2021121010415127600_B41","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pd.2145","article-title":"Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies","volume":"28","author":"Garchet-Beaudron","year":"2008","journal-title":"Prenat Diagn"},{"issue":"11","key":"2021121010415127600_B42","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/pd.4431","article-title":"Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis","volume":"34","author":"Prats","year":"2014","journal-title":"Prenat Diagn"},{"issue":"5","key":"2021121010415127600_B43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.semperi.2005.08.005","article-title":"Prenatal diagnosis and multiple pregnancy","volume":"29","author":"Cleary-Goldman","year":"2005","journal-title":"Semin Perinatol"},{"issue":"6","key":"2021121010415127600_B44","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/uog.20284","article-title":"Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis","volume":"53","author":"Gil","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"2021121010415127600_B45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1701-2163(15)30261-9","article-title":"Technical Update: preimplantation genetic diagnosis and screening","volume":"37","author":"Dahdouh","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"2021121010415127600_B46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.fertnstert.2020.07.052","article-title":"A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy","volume":"115","author":"Tiegs","year":"2021","journal-title":"Fertil Steril"},{"issue":"5","key":"2021121010415127600_B47","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.fertnstert.2017.02.121","article-title":"Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion","volume":"107","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2017","journal-title":"Fertil Steril"},{"issue":"3","key":"2021121010415127600_B48","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/AOG.0000000000003714","article-title":"Preimplantation genetic testing: ACOG committee opinion, number 799","volume":"135","author":"Preimplantation Genetic Testing","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2021121010415127600_B49","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/s41436-019-0467-4","article-title":"Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes","volume":"21","author":"Liang","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"2021121010415127600_B50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13039-021-00550-5","article-title":"Clinical application of noninvasive prenatal testing in the detection of fetal chromosomal diseases","volume":"14","author":"Pang","year":"2021","journal-title":"Mol Cytogenet"},{"journal-title":"Prenat Diagn","article-title":"Overview and recent developments in cell-based noninvasive prenatal testing. [published online ahead of print May 11, 2021]","author":"Vossaert","key":"2021121010415127600_B51"},{"issue":"6","key":"2021121010415127600_B52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/aogs.13880","article-title":"Do fetal extravillous trophoblasts circulate in maternal blood postpartum?","volume":"99","author":"van de Looij","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"2021121010415127600_B53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/pd.5150","article-title":"On the road to replacing invasive testing with cell-based NIPT: Five clinical cases with aneuploidies, microduplication, unbalanced structural rearrangement, or mosaicism","volume":"37","author":"Vestergaard","year":"2017","journal-title":"Prenat Diagn"},{"issue":"6","key":"2021121010415127600_B54","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.fertnstert.2021.04.002","article-title":"Noninvasive preimplantation genetic testing for aneuploidy: Is the glass half-empty or half-full?","volume":"115","author":"Rubio","year":"2021","journal-title":"Fertil Steril"},{"issue":"1","key":"2021121010415127600_B55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/humupd\/dmz033","article-title":"Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics?","volume":"26","author":"Leaver","year":"2020","journal-title":"Hum Reprod Update"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/12\/e805\/1207810\/neoreviews_082021cmerev00144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/12\/e805\/1207810\/neoreviews_082021cmerev00144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T12:09:33Z","timestamp":1699877373000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/22\/12\/e805\/183454\/Fetal-Screening-for-Chromosomal-Abnormalities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,1]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.22-12-e805","relation":{},"ISSN":["1526-9906"],"issn-type":[{"type":"electronic","value":"1526-9906"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}